Etienne Gayat

Etienne Gayat

Auto-generated profile, based on publicly available information

Etienne Gayat

Department of Anesthesiology, Burn and Critical Care, University Hospitals Saint-Louis—Lariboisière, AP-HP, Paris, France

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2013 in Critical Care
Verified
Journal Article
Open access
PDF file
MLMatthieu Legrand
Matthieu Legrand
CDClaire Dupuis
Claire Dupuis
CSChristelle Simon
Christelle Simon
EGEtienne Gayat
Etienne Gayat
JMJoaquim Mateo
Joaquim Mateo
Didier PayenDidier Payen
Didier Payen
Introduction: The role of systemic hemodynamics in the pathogenesis of septic acute kidney injury (AKI) has received little attention. The purpose of this study was to investigate the association between systemic hemodynamics and new or persistent of AKI in severe sepsis. Methods: A retrospective study between 2006 and 2010 was performed in a surgical ICU in a teaching hospital. AKI was defined as development (new AKI) or persistent AKI during the five days following admission based on the Acute Kidney Injury Network (AKIN) criteria. We studied the association between the following hemodynamic targets within 24 hours of admission and AKI: central venous pressure (CVP), cardiac output (CO), mean arterial pressure (MAP), diastolic arterial pressure (DAP), central venous oxygen saturation (ScvO2) or mixed venous oxygen saturation (SvO2). Results: This study included 137 ICU septic patients. Of these, 69 had new or persistent AKI. AKI patients had a higher Simplified Acute Physiology Score (SAPS II) (57 (46 to 67) vs. 45 (33 to 52), P < 0.001) and higher mortality (38% vs. 15%, P = 0.003) than those with no AKI or improving AKI. MAP, ScvO2 and CO were not significantly different between groups. Patients with AKI had lower DAP and higher CVP (P = 0.0003). The CVP value was associated with the risk of developing new or persistent AKI even after adjustment for fluid balance and positive end-expiratory pressure (PEEP) level (OR = 1.22 (1.08 to 1.39), P = 0.002). A linear relationship between CVP and the risk of new or persistent AKI was observed. Conclusions: We observed no association between most systemic hemodynamic parameters and AKI in septic patients. Association between elevated CVP and AKI suggests a role of venous congestion in the development of AKI. The paradigm that targeting high CVP may reduce occurrence of AKI should probably be revised. Furthermore, DAP should be considered as a potential important hemodynamic target for the kidney.

6 January 2011 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
FFF. Follath
F. Follath
MYMehmet Birhan Yilmaz
Mehmet Birhan Yilmaz
Juan F. Delgado JiménezJuan F. Delgado Jiménez
Juan F. Delgado Jiménez
JPJ. T. Parissis
J. T. Parissis
RPR. Porcher
R. Porcher
AMAlexandre Mebazaa
Alexandre Mebazaa

1 October 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
JLJohan Lassus
Johan Lassus
EGEtienne Gayat
Etienne Gayat
CMChristian Mueller
Christian Mueller
WPW.Frank Peacock
W.Frank Peacock
JSJindrich Spinar
Jindrich Spinar
AMAlexandre Mebazaa
Alexandre Mebazaa

18 November 2010 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
AMAlexandre Mebazaa
Alexandre Mebazaa
JPJohn Parissis
John Parissis
RPRaphael Porcher
Raphael Porcher
EGEtienne Gayat
Etienne Gayat
MNMaria Nikolaou
Maria Nikolaou
FFFerenc Follath
Ferenc Follath

18 January 2018 in Critical Care
Verified
Journal Article
Open access
PDF file
EGEtienne Gayat
Etienne Gayat
ACAlain Cariou
Alain Cariou
NDNicolas Deye
Nicolas Deye
AVAntoine Vieillard-Baron
Antoine Vieillard-Baron
SJSamir Jaber
Samir Jaber
AMAlexandre Mebazaa
Alexandre Mebazaa
Intensive care unit (ICU) survivors have reduced long-term survival compared to the general population. Identifying parameters at ICU discharge that are associated with poor long-term outcomes may prove useful in targeting an at-risk population. The main objective of the study was to identify clinical and biological determinants of death in the year following ICU discharge. FROG-ICU was a prospective, observational, multicenter cohort study of ICU survivors followed 1 year after discharge, including 21 medical, surgical or mixed ICUs in France and Belgium. All consecutive patients admitted to intensive care with a requirement for invasive mechanical ventilation and/or vasoactive drug support for more than 24 h following ICU admission and discharged from ICU were included. The main outcome measure was all-cause mortality at 1 year after ICU discharge. Clinical and biological parameters on ICU discharge were measured, including the circulating cardiovascular biomarkers N-terminal pro-B type natriuretic peptide, high-sensitive troponin I, bioactive-adrenomedullin and soluble-ST2. Socioeconomic status was assessed using a validated deprivation index (FDep). Of 1570 patients discharged alive from the ICU, 333 (21%) died over the following year. Multivariable analysis identified age, comorbidity, red blood cell transfusion, ICU length of stay and abnormalities in common clinical factors at the time of ICU discharge (low systolic blood pressure, temperature, total protein, platelet and white cell count) as independent factors associated with 1-year mortality. Elevated biomarkers of cardiac and vascular failure independently associated with 1-year death when they are added to multivariable model, with an almost 3-fold increase in the risk of death when combined (adjusted odds ratio 2.84 (95% confidence interval 1.73–4.65), p < 0.001). The FROG-ICU study identified, at the time of ICU discharge, potentially actionable clinical and biological factors associated with poor long-term outcome after ICU discharge. Those factors may guide discharge planning and directed interventions. ClinicalTrials.gov NCT01367093 . Registered on 6 June 2011.

11 November 2009 in European Heart Journal
Verified
Journal Article
Open access
PDF file
AMAlexandre Mebazaa
Alexandre Mebazaa
PPPeter S. Pang
Peter S. Pang
MTMiguel Tavares
Miguel Tavares
SCSean P. Collins
Sean P. Collins
ASAlan B. Storrow
Alan B. Storrow
MGMihai Gheorghiade
Mihai Gheorghiade
The vast majority of acute heart failure (AHF) trials to date have targeted dyspnoea. However, they enrolled patients relatively late and did not standardize their methods of dyspnoea measurement. URGENT Dyspnoea was designed to determine changes in dyspnoea in response to initial, standard therapy in patients presenting with AHF using a standardized approach. URGENT Dyspnoea was an international, multi-centre, observational cohort study of AHF patients managed conventionally and enrolled within 1 h of first hospital medical evaluation. Patient-assessed dyspnoea was recorded in the sitting position at baseline and at 6 hours by Likert and visual analog scales. Less symptomatic patients were placed supine to determine whether this provoked worsening dyspnoea (orthopnoea). Of the 524 patients with AHF, the mean age was 68 years, 43% were women, and 83% received intravenous diuretics. On a 5-point Likert scale, dyspnoea improvement was reported by 76% of patients after 6 h of standard therapy. Supine positioning (orthopnoea test) led to worse dyspnoea in 47% of patients compared to sitting upright. When sitting upright, dyspnoea in the sitting position improves rapidly and substantially in patients with AHF after administration of conventional therapy, mainly intra-venous diuretics. However, many patients remain orthopnoeic. Improving the methodology of clinical trials in AHF by standardizing the conditions under which dyspnoea is assessed could enhance their ability to identify effective treatments. Relief of orthopnoea is clinically valuable and may represent a useful goal for clinical trials.